Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kyowa Pharmaceutical

Kyowa Pharmaceutical
1954 FOUNDED
M&A STATUS
601-700 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer and supplier of pharmaceutical intended to benefit medical community and human health. The company's product portfolio mainly consists of a wide range of psychiatric and neurological products including psychotropics, hypnotics and sedative, anxiolytics, antihypertensives, and vasodilators, along with hyperlipidemia, peptic ulcer, antiallergic, antidiabetic, hyperlipidemia, peptic ulcer, and allergic agents, enabling physicians to provide better psychiatric and neurological treatments.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Parent Company
Primary Office
  • 3-2-4, Nakanoshima, Kita-ku
  • Osaka, 530-0005
  • Japan

+81 00-0000-0000

Kyowa Pharmaceutical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Kyowa Pharmaceutical‘s full profile, request access.

Request full access to PitchBook

Kyowa Pharmaceutical Executive Team (2)

Name Title Board
Seat
Contact
Info
Ray Tsunoda President & Representative Director
Fabrice Egros Ph.D Chairman & Representative Director

Kyowa Pharmaceutical Board Members (1)

Name Representing Role Since Contact
Info
0000000 00000 00.0 Kyowa Pharmaceutical Chairman & Representative Director 000 0000